AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 396 filers reported holding AMEDISYS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,218,530 | -8.4% | 342,876 | +4.0% | 0.18% | -16.0% |
| Q4 2022 | $27,535,202 | -10.3% | 329,605 | +3.9% | 0.21% | -13.1% |
| Q3 2022 | $30,699,000 | -9.0% | 317,175 | -1.2% | 0.24% | -8.3% |
| Q2 2022 | $33,744,000 | -33.5% | 321,006 | +9.0% | 0.27% | -18.2% |
| Q1 2022 | $50,716,000 | +5.0% | 294,367 | -1.4% | 0.32% | +13.2% |
| Q4 2021 | $48,315,000 | +43.6% | 298,459 | +32.3% | 0.29% | +41.4% |
| Q3 2021 | $33,639,000 | -16.5% | 225,617 | +37.2% | 0.20% | -15.8% |
| Q2 2021 | $40,286,000 | -12.0% | 164,481 | -4.8% | 0.24% | -15.1% |
| Q1 2021 | $45,768,000 | -15.7% | 172,845 | -6.6% | 0.28% | -11.8% |
| Q4 2020 | $54,284,000 | +30.8% | 185,060 | +5.4% | 0.32% | +19.7% |
| Q3 2020 | $41,498,000 | -32.3% | 175,519 | -43.1% | 0.27% | -36.3% |
| Q2 2020 | $61,295,000 | +64.3% | 308,728 | +51.9% | 0.42% | +28.3% |
| Q1 2020 | $37,302,000 | – | 203,236 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |